Marinus Pharma (MRNS) Earnings
|
Expand Research on MRNS
| Next EPS Date | 5/9/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +2.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -10.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/9/24 | Q124 | N/A | -$0.65 | N/A | N/A | $9.04M | = | N/A | N/A | ||
| 3/5/24 | Q423 | -$0.74 | -$0.62 | -$0.12 | $7.19M | $7.97M | = |  | | Details | |
| 11/7/23 | Q323 | -$0.61 | -$0.66 | +$0.05 | $7.34M | $6.28M | N/A | | | Details | |
| 8/10/23 | Q223 | -$0.61 | -$0.72 | +$0.11 | $6.08M | $5.71M | N/A | | | Details | |
| 5/11/23 | Q123 | -$0.67 | -$0.73 | +$0.06 | $10.38M | $5.76M | N/A | | | Details | |
5/3/23  |
Q123 | N/A | -$0.73 | N/A | N/A | $5.76M | N/A | N/A | N/A | ||
| 3/7/23 | Q422 | -$0.76 | -$0.62 | -$0.14 | $7.16M | $9.07M | N/A | | | Details | |
| 11/7/22 | Q322 | -$0.53 | -$0.99 | +$0.46 | $10.11M | $3.01M | N/A | | | Details |
